Cargando…
An Investigator-Blind Randomized Controlled Trial Comparing Effectiveness, Safety of Levocetirizine and Bepotastine in Chronic Urticaria
INTRODUCTION: Chronic urticaria is common and distressing dermatosis where the search for newer agents with improved effectiveness and tolerability profile is a felt need. Bepotastine, a second-generation antihistamine, with added effect on suppression of eosinophil migration has a prospect in the m...
Autores principales: | Sil, Amrita, Rahaman, Sufiur, Mondal, Nasiruddin, Ahmed, Sk Shahriar, Tarafdar, Dhiman, Patra, Aparesh Chandra, Roy, Sudipta, Das, Nilay Kanti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751697/ https://www.ncbi.nlm.nih.gov/pubmed/35068500 http://dx.doi.org/10.4103/ijd.ijd_813_20 |
Ejemplares similares
-
Bepotastine-induced urticaria, cross-reactive with other antihistamines
por: Kang, Ju Wan, et al.
Publicado: (2016) -
Autologous Serum Therapy in Chronic Urticaria: A Promising Complement to Antihistamines
por: Debbarman, Panchami, et al.
Publicado: (2014) -
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
por: Staevska, Maria T
Publicado: (2016) -
Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
por: Nettis, E, et al.
Publicado: (2008) -
Perception of Leprosy Patients towards the Disease in a Tertiary Care Hospital of High Prevalent District in West Bengal, India: A Qualitative Study
por: Datta, Jayanti, et al.
Publicado: (2022)